Literature DB >> 17661668

Etiological diagnosis of pericardial effusion.

Pierre-Yves Levy1, Gilbert Habib, Fréderic Collart, Hubert Lepidi, Didier Raoult.   

Abstract

Detection and treatment of pericarditis remains a challenging problem and the etiology is unknown in 40-85% of cases. As a result, a large proportion of cases are labeled idiopathic pericarditis. The advent of echocardiography, an accurate noninvasive method for the detection of effusion, has clarified the definition from pericarditis to pericardial effusion, which is a standardized and clear entity. A systematic approach to diagnostic testing based on standardized practice guidelines has been proposed. This strategy has led to a decrease in the number of cases classified as idiopathic and to the identification of treatable conditions. Percutaneous pericardiocentesis, guided by fluoroscopy or echocardiography, can now be carried out safely and rapidly and has also allowed the intrapericardial instillation of drugs, representing a new treatment strategy. The inclusion of flexible pericardioscopy, immunohistochemistry and contemporary molecular biology tools has improved the diagnostic value of the biopsy.

Entities:  

Mesh:

Year:  2006        PMID: 17661668     DOI: 10.2217/17460913.1.2.229

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  3 in total

1.  Malignancy with unknown primary presenting as acute cardiac tamponade: a case report.

Authors:  Edward J Banham-Hall; Awais M Bokhari
Journal:  Cases J       Date:  2009-06-18

2.  Viral communities associated with human pericardial fluids in idiopathic pericarditis.

Authors:  Laura Fancello; Sonia Monteil; Nikolay Popgeorgiev; Romain Rivet; Frédérique Gouriet; Pierre-Edouard Fournier; Didier Raoult; Christelle Desnues
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

3.  Analysis of pericardial effusion from idiopathic pericarditis patients by two-dimensional gel electrophoresis.

Authors:  Sadan Yavuz; Murat Kasap; Gurler Akpinar; Ersan Ozbudak; Dilek Ural; Turan Berki
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.